FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to chronomedicine, endocrinology, dietology and therapy, and can be used to assess individual metabolic risk by circadian light hygiene. Following factors are taken into account in points: the latitude of the region of residence taking into account the seasonality of the estimate calculation, the obtained daylight according to the survey data, the regular screen time, the polymorphism of the melatonin receptor gene MTNR1B rs10830963 and the polymorphism of the clock gene CLOCK rs1801260. Further, the scores are summed up and the metabolic risk is assessed as a minimum with a total score of 5 and less, an average risk with a total score of 6 to 10, inclusive, and a high metabolic risk with a total score of 11 and more.
EFFECT: method provides the effective assessment of the individual metabolic risk by circadian light hygiene by taking into account the factors modifying the effect on metabolism.
1 cl, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE USING ACTIGRAPHY | 2024 |
|
RU2830419C1 |
| METHOD FOR QUANTITATIVE ASSESSMENT OF CIRCADIAN EQUILIBRIUM ACCORDING TO ACTIGRAPHY DATA | 2024 |
|
RU2834158C1 |
| METHOD FOR DETERMINING BLOOD TRIGLYCERIDES TAKING INTO ACCOUNT BIOLOGICAL CLOCK PHASE | 2024 |
|
RU2834162C1 |
| METHOD FOR INTEGRATIVE ASSESSMENT OF SLEEP IN ACTIGRAPHY | 2024 |
|
RU2833895C1 |
| METHOD FOR ASSESSING THE RISK OF TYPE 2 DIABETES MELLITUS BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2786822C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD FOR ESTIMATING THE RISK OF OCCURRENCE OF PSYCHOLOGICAL SLEEP AND MOOD DISORDERS BASED ON THE ADJUSTED AVERAGE SLEEP STAGE ACCORDING TO THE MUNICH QUESTIONNAIRE | 2021 |
|
RU2762914C1 |
| METHOD FOR DIAGNOSIS OF LIGHT DESYNCHRONOSIS | 2020 |
|
RU2748686C1 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING DISEASES OF THE CARDIOVASCULAR SYSTEM BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2786829C1 |
| METHOD FOR ASSESSING THE RISK OF CERTAIN DISEASES OF THE RESPIRATORY SYSTEM BASED ON THE AVERAGE ADJUSTED SLEEP PHASE ACCORDING TO THE MUNICH TEST | 2022 |
|
RU2781888C1 |
